![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 19, 16624-16631, May 10, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Fox Chase Cancer Center, Institute for Cancer Research,
Philadelphia, Pennsylvania 19111
Received for publication, October 31, 2001, and in revised form, February 25, 2002
S-Adenosylmethionine synthetase
(ATP:L-methionine S-adenosyltransferase, MAT)
catalyzes a unique enzymatic reaction that leads to formation of the
primary biological alkylating agent. MAT from the hyperthermophilic
archaeon Methanococcus jannaschii (MjMAT) is a
prototype of the newly discovered archaeal class of MAT proteins that are nearly unrecognizable in sequence when compared with the class
that encompasses both the eucaryal and bacterial enzymes. In
this study the functional properties of purified recombinant MjMAT have
been evaluated. The products of the reaction are AdoMet, PPi, and Pi; >90% of the Pi
originates from the S-Adenosylmethionine
(AdoMet)1 occupies a central
role in the metabolism of all cells. The biological roles of AdoMet
include acting as the primary methyl group donor, as a precursor to the polyamines, and as a progenitor of a 5'-deoxyadenosyl radical (1-5).
S-Adenosylmethionine synthetase
(ATP:L-methionine S-adenosyltransferase; also
known as methionine adenosyltransferase (MAT), EC 2.5.1.6) catalyzes
the only known route of AdoMet biosynthesis (6-9). The synthetic
process occurs in a unique reaction in which the complete triphosphate
chain is displaced from ATP and a sulfonium ion formed (6, 9). MATs
from various organisms contain ~400-amino acid polypeptide chains.
However we have recently found that the protein sequences comprise two
categories, the extensively studied eucaryal-bacterial type (encoded by
a catalytic subunit denoted The AdoMet synthetic reaction catalyzed by the The present work has investigated the functional properties of MAT from
M. jannaschii, which is the first of the archaeal class to
be readily available in substantial amounts as a result of cloning and
expression in E. coli (11).
Reagents were purchased from Sigma unless noted. AdoMet was
purchased from Research Biochemicals International.
5-Mercapto-5'-deoxy-ATP (A(S)TP), 5-amino-5'-deoxy-ATP (A(NH)TP),
purine triphosphate, 3-deaza-ATP, and 7-deaza-ATP were synthesized as
described previously (13-16). Diimidotriphosphate
(O3P-NH-PO2-NH-PO3; PNPNP) was
synthesized by the Organic Synthesis Facility at FCCC as described (15, 17). L-[methyl-14C]Methionine and
H333PO4 were purchased from
PerkinElmer Life Sciences.
[carboxy-14C]AdoMet, [8-14C]ATP,
and [ MjMAT Purification--
Recombinant M. jannaschii
AdoMet synthetase was prepared from the strain BL21(DE3)(codon
plus)/pMJ1208-1. This protein has a decahistidine tag on the N terminus
(11). Cells were grown at 37 °C in LB medium containing 50 µg/ml
carbenecillin. Induction of MjMAT expression was obtained by addition
of 1 mM
isopropyl-1-thio-
The cell pellet was suspended in 50 mM Tris·HCl, 1 mM DTT, 30 µM phenylmethylsulfonyl fluoride,
pH 8, using 10 ml of buffer/g (wet weight) of cells. The cells were
lysed by one pass through a French press at 10,000 p.s.i. Debris was
removed by centrifugation at 13,000 × g for 30 min.
Ammonium sulfate was added to the supernatant to 20% saturation, and
the insoluble material was removed by centrifugation. Ammonium sulfate
was then added to the supernatant to 80% saturation, and the pellet
was collected by centrifugation.
The scale of following steps is described for a preparation from
25 g (wet weight) of cells. The ammonium sulfate pellet was dissolved in ~20 ml of Buffer A (containing 50 mM
Tris·HCl, 1 mM DTT, pH 8) and dialyzed overnight at
4 °C against 2 liters of the same buffer. The protein was divided
into 5-ml portions and heated in a 85 °C water bath for 30 min.
Precipitated materials were removed by centrifugation.
Chromatographic steps were performed at room temperature. The protein
was dialyzed overnight into 50 mM Tris·HCl, pH 8, and then NaCl and imidazole were added to final concentrations of 300 and 5 mM, respectively. The sample was loaded onto a 2 × 15-cm column of Ni2+-His·Bind resin (Novagen) that was
equilibrated with 50 mM Tris·HCl, 300 mM
NaCl, 5 mM imidazole, pH 8. The column was washed with 80 ml of starting buffer (at a flow rate of 1.0 ml/min) and eluted with a
200-ml gradient from the starting buffer to a final buffer of 50 mM Tris·HCl, 300 mM NaCl, 500 mM
imidazole, pH 8. The fractions containing activity were dialyzed
overnight against 50 mM Tris·HCl, 1 mM DTT,
pH 8, and stored at
Minor contaminants were subsequently removed by ion exchange and gel
filtration chromatography. Before ion exchange chromatography, the
protein was equilibrated in 25 mM MES, 1 mM
DTT, pH 6, by dialysis. The protein was loaded onto a HiLoad
Q-Sepharose (Amersham Biosciences) column (2.6 × 12 cm)
equilibrated and washed with 100 ml of dialysis buffer (at a flow rate
of 2.5 ml/min), and the protein was eluted with a 500-ml gradient of
this buffer also containing 0.7 M KCl. The active fractions
were pooled and dialyzed against 50 mM Tris·HCl, 50 mM KCl, 1 mM DTT, pH 8. Final purification was
obtained by gel filtration chromatography of 2-ml aliquots on a 2 × 60-cm Superdex-200 column (Amersham Biosciences) equilibrated and
eluted at 0.5 ml/min with 50 mM Tris·HCl, 50 mM KCl, 1 mM DTT, pH 8.0. The final protein
displayed a single band on Coomassie Blue-stained 8-25% gradient
polyacrylamide Phast gels (Amersham Biosciences) in the presence and
absence of SDS. The concentration of purified MjMAT was estimated from
the absorbance at 280 nm using an extinction coefficient of 1.0 (mg/ml)
E. coli AdoMet synthetase (EcMAT) was purified as described
previously (20).
AdoMet synthetase activity was determined by a
[14C]AdoMet cation exchange filter binding method (20).
Assays were performed at 55 °C in 25 mM
Hepes·(CH3)4N+ at pH 8.0 with 50 mM KCl, and 10 mM MgCl2. Routine
assays contained 9.5 mM ATP and 0.5 mM
[methyl-14C]methionine. Substrate saturation
data were evaluated using the kinetic equations of Cleland (21) or the
kinetics module of Sigmaplot 2000 (SPSS Science), which utilizes the
Segel formalism (22). All fits were consistent with linear dependence
of activity on substrate and/or inhibitor concentration. Inhibition
studies were conducted with substrate concentrations near their
Km values.
The activation energy for AdoMet synthesis, Ea,
was calculated from the slope of linear ranges of an Arrhenius plot of
ln(kcat) versus 1/T
(slope =
The phosphorus-containing reaction products were identified by
evaluating PPPi, PPi, and Pi
formation from [
The reverse reaction was examined in two ways: by looking for either
the formation of [carboxy-14C]methionine from
[carboxy-14C]AdoMet or the formation of
[33P]ATP or 33PPPi from
33Pi. In the first case, 0.2 mM
[carboxy-14C]AdoMet (56 mCi/mmol), 5 mM PPi, and 5 mM Pi
were incubated with 1 mg/ml enzyme in 0.1 M Tris·Cl, 50 mM KCl, 10 mM MgCl2 for up to 60 min at 55 °C. Compounds were separated by thin layer chromatography on cellulose sheets developed in n-butyl alcohol:acetic
acid:water (25:4:10) in which AdoMet and methionine have
RF values of 0.26 and 0.56, respectively.
Radioactivity was quantified by phosphorimaging. In the latter case, 5 mM AdoMet, 5 mM PPi, and 5 mM 33Pi (11 mCi/mmol) were
incubated with 1 mg/ml enzyme for up to 60 min at 55 °C. Compounds
were separated by thin layer chromatography on
polyethyleneimine-cellulose sheets and radioactivity quantified as
described above.
Circular Dichroism (CD) Spectra--
Protein secondary structure
was assessed from circular dichroism spectra obtained on an Aviv model
62A spectropolarimeter. Samples (0.3 mg/ml protein in 25 mM
Tris·HCl, 25 mM KCl, pH 8.0) were placed in 1-mm path
length cells; spectra were recorded from 200 to 260 nm and were
corrected for buffer contributions.
Recombinant MjMAT was purified to electrophoretic homogeneity from
E. coli as described under "Experimental Procedures."
The protein was allowed to retain an N-terminal decahistidine tag, because we had found that the properties of the recombinant protein were comparable with those of the protein isolated from M. jannaschii (11). Recombinant MjMAT chromatographed with a
Mr of 86,000 on gel filtration, consistent with
its being a dimer of 45-kDa subunits (11). The purified enzyme readily
crystallizes under a variety of common
conditions,2 and attempts to
obtain diffraction quality crystals are in progress.
CD spectra were compared for MjMAT and the E. coli enzyme to
assess potential similarities in secondary structure (Fig.
1). MjMAT displays substantially larger
ellipticity at 220 nm, a wavelength characteristic of the proportion of
Enzymatic Properties of S-Adenosylmethionine
Synthetase from the Archaeon Methanococcus jannaschii*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-phosphoryl group of ATP. The circular dichroism
spectrum of the dimeric MjMAT indicates that the secondary structure is
more helical than the Escherichia coli counterpart (EcMAT),
suggesting a different protein topology. The steady state kinetic
mechanism is sequential, with random addition of ATP and methionine;
AdoMet is the first product released, followed by release of
PPi and Pi. The substrate specificity differs remarkably from the previously characterized MATs; the nucleotide binding site has a very broad tolerance of alterations in the adenosine
moiety. MjMAT has activity at 70 °C comparable with that of EcMAT at
37 °C, consistent with the higher temperature habitat of M. jannaschii. The activation energy for AdoMet formation is larger
than that for the E. coli MAT-catalyzed reaction, in accord
with the notion that enzymes from thermophilic organisms are often more
rigid than their mesophilic counterparts. The broad substrate tolerance
of this enzyme proffers routes to preparation of novel AdoMet analogs.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
(Ref. 10)) and the newly recently
discovered archaeal type (encoded by a subunit that we denote
(Ref.
11));
chains encode a regulatory subunit for the
class (10).
Within each category the sequences are highly conserved,
e.g. there is 59% identity between the human and
Escherichia coli MAT
subunits. In contrast, the
sequences of the two classes are widely diverged, e.g. there
is only 22% identity between the Methanococcus jannaschii
-type MAT and either the E. coli or human
subunits.
The variation in sequence follows evolutionary lines and is not simply
related to the habitat of the organism because MATs from
hyperthermophilic bacteria and archaea fall in the same classes as MATs
from mesophiles of the same kingdom (11). None of the MAT sequences is
discernibly related to that of any other known protein.
class MATs is
composed of two sequential steps, AdoMet formation and the subsequent
hydrolysis of tripolyphosphate (PPPi) as depicted
below.
The Pi formed during the MAT-
-catalyzed reaction
originates predominantly from the
-phosphoryl group of ATP (6). Both divalent cations (e.g. Mg2+) and monovalent
cations (e.g. K+) are required for maximal
activity. Whether the same catalytic mechanism operates with the
archaeal enzyme, particularly at elevated temperature, is of interest
in view of the unclear role of PPPi hydrolysis in the
thermodynamics of AdoMet formation (12).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-33P]ATP were purchased from Moravek
Biochemicals. Ecoscint scintillation fluid was purchased from National
Diagnostics. L-cis-2-Amino-4-methoxybut-3-enoic acid (18) was a generous gift from Dr. Janice Sufrin (Roswell Park
Cancer Institute, Buffalo, NY).
-D-galactopyranoside to a 20-fold
dilution of an overnight culture and shaking for 3 h. Cells were
harvested by centrifugation and stored at
80 °C until use.
80 °C.
1 cm
1 as calculated from the amino
acid composition (19). Approximately 50 mg of enzyme were obtained from
15 g (wet weight) of cells.
Ea/R). The free
energy of activation,
G#, was calculated as
G# = RT(ln(kBT/h)
ln(kcat)) where R = 1.9872 cal/mol-K, kB is the Boltzmann constant,
h is Planck's constant, and kcat is
the value measured at temperature T. The activation
enthalpy,
H#, was calculated as
(Ea
RT). The activation entropy
S# was then obtained from
(
H#
G#)/T (23). A more complete
analysis of the temperature dependence of reaction rates considers that
nonlinearity of an Arrhenius plot may arise from heat capacity change
during the reaction,
Cp# (24).
Thus, with respect to a reference temperature
(T0, defined as 37 °C), at a given
temperature T,
H#(T) =
H#(T0) +
Cp#(T
T0) and
S#(T) =
#(T0) +
Cp#(ln(T/T0)).
These relationships were used in fitting the observed data for MjMAT
via nonlinear least squares using the program Scientist (MicroMath
Inc.).
-33P]ATP in the presence and absence
of inorganic pyrophosphatase. Compounds were separated by thin layer
chromatography on polyethyleneimine-cellulose anion exchange thin layer
sheets (EM Science) developed in 0.9 M LiCl, 50 mM EDTA, pH 7. The radiation was quantified using a Fuji
phosphorimager. A 33PPPi standard was
prepared from the [
-33P]ATP by periodate oxidation
followed by aniline cleavage (12, 25); 33PPi
was prepared from 33PPPi using E. coli MAT. Solutions contained 5 mM ATP (4.4 × 104 cpm/nmol), 5 mM methionine, 1 mg/ml MjMAT,
100 mM Hepes, pH 8, 50 mM KCl, 10 mM MgCl2; when present, 0.025 units/µl
inorganic pyrophosphatase were added. Time points were taken from 1 to
60 min. ATP was removed from the reactions by adsorption to Norit before TLC (12). ATP, Pi, PPi, and
PPPi standards had RF values of
0.27, 0.8, 0.13, and 0.04, respectively. After 4 h, ~77% of the
33P was present as Pi.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helix. The crystal structures of the E. coli and rat
liver enzymes show that they are composed of ~25%
-helix and
~20%
-sheet (26, 27). The differences in CD spectra suggest that
the overall secondary structure of MjMAT is more helical than the
eucaryal or bacterial MAT-
.

View larger version (15K):
[in a new window]
Fig. 1.
Circular dichroism spectra of MAT from
E. coli and M. jannaschii.
Spectra were obtained at 0.3 mg/ml protein in 25 mM
Tris·HCl, 25 mM KCl, pH 8.0, and were corrected for
buffer contributions. Open circles, E. coli MAT; closed circles, M
jannaschii MAT.
Origin of the Pi Formed in the Reaction--
A notable
feature of MAT-
-catalyzed reaction is that the products released
from the enzyme are PPi and Pi, rather than
PPPi initially formed in conjunction with AdoMet synthesis.
The PPPi formed as an intermediate is primarily hydrolyzed
even before it can reorient, with the result that >95% Pi
originates from the
-phosphoryl group of ATP (6). Our previous
studies of MjMAT demonstrated that PPi and Pi
were formed as products (11). When the products formed in the
MjMAT-catalyzed reaction from [
-33P]ATP were analyzed,
33Pi constituted 93% of the product and 7%
was present in 33PPi;
33PPPi was not detected. Thus, even at the
55 °C temperature used in this experiment, the PPPi
initially created upon AdoMet synthesis neither dissociates from the
enzyme nor readily reorients before hydrolysis, and Pi
primarily originates from the
-phosphoryl group of ATP
(11).
Irreversibility of the Reaction--
Attempts were made to measure
the reverse reaction by conversion of
[carboxy-14C]AdoMet or
33Pi to radiolabeled methionine or ATP,
respectively (see "Experimental Procedures"). In neither case was
any reaction observed, even using levels of enzyme and reaction times
where 0.1% conversion could be measured; less than 0.1 eq of ATP,
PPPi, or AdoMet, per enzyme subunit, was formed in a
2500-fold longer time than that required for a single turnover in the
forward direction. Thus, reversal of both the AdoMet forming and the
PPPi hydrolytic steps appears to be unfavorable. This
result is concordant with the established kinetic as well as
thermodynamic irreversibility of AdoMet synthesis in reactions
catalyzed by the
-type enzyme (6, 12).
Cation Activation--
No reaction was detected in the absence of
Mg2+, consistent with the divalent cation requirement of
other MATs. K+ both enhanced the
kcat by 5-fold and decreased the
Km values for both substrates, with half-maximal
effect at 5 mM (Fig. 2).
Saturating KCl decreased the Km for ATP from 1.4 to
0.22 mM and the Km for methionine from
1.1 to 0.3 mM. Plots of 1/v versus
1/K+ at different substrate concentrations (and the
converse) did not intersect on the 1/v axis, showing that
the cation and substrate binding are not related by an equilibrium
ordered binding process. The data indicate that K+ is a
stimulator rather than an essential activator, in common with the
-type MATs.
|
Kinetic Mechanism--
Substrate saturation kinetic studies of the
AdoMet synthetic reaction show that MjMAT catalyzes a sequential
reaction in which both ATP and methionine bind before products are
released (Fig. 3,
A and B). The Km values do not
vary substantially with the concentrations of co-substrate, indicating
little synergism in binding affinity.
|
An ATP analog that contains a C5'-S-P linkage was not a substrate for
AdoMet formation, but was a competitive inhibitor with respect to ATP
and noncompetitive with respect to methionine (Fig. 3, C and
D), with a Ki comparable with the
Km for ATP (Table I).
The alternate substrate GTP was also a competitive inhibitor with
respect to ATP and noncompetitive with methionine (AdoMet formation was
measured with [8-14C]ATP in these inhibition
experiments). A nonreactive analog of methionine that has high affinity
was not identified. Cycloleucine, 1-amino-1-carboxy-cyclopentane, is a
commonly used dead-end inhibitor of the
-type enzymes (28). However,
20 mM cycloleucine gave no detectable inhibition of MjMAT,
even with both the substrates present at their Km
values. Furthermore, MjMAT was not significantly inhibited (<10%) by
10 mM concentrations of L-homocysteine, L-norleucine, or
L-cis-2-amino-4-methoxy-3-butenoic acid (the most potent methionine analog inhibitor of MAT-
(Ref. 18)). The
alternate substrates L-ethionine and
L-methionine methyl ester were competitive inhibitors with
respect to methionine for AdoMet formation from
[methyl-14C]methionine, and noncompetitive
inhibitors with respect to ATP (cf. Fig. 3, E and
F). The observed pattern of inhibition by nonreactive compounds and alternate substrates indicates that substrate binding is
random. Both ethionine and methionine methyl ester have much smaller
Km values than their Ki values
for inhibition of the reaction with methionine (6- and 70-fold,
respectively), suggesting the presence of substantial kinetic
contributions to the Km. The noncompetitive
inhibition toward methionine by nonreactive ATP analogs reflects
formation of dead-end enzyme-substrate-inhibitor complexes (21,
22).
|
Product inhibition studies showed that AdoMet is a noncompetitive
inhibitor with respect to both methionine and ATP with
Ki values near 2 mM (Fig. 3,
G and H). This high Ki
contrasts with that of most
-type MATs for which AdoMet is a potent
inhibitor with Ki values in the ~10
5
M range. Pyrophosphate is a competitive inhibitor with
respect to ATP (Ki = 0.83 mM) and
noncompetitive with respect to methionine (Fig. 3, I and
J). Phosphate is a competitive inhibitor toward
both ATP and methionine, with Ki values
comparable with the Ki for PPi (Fig. 3,
K and L). The product inhibition results indicate
that product release is ordered with AdoMet dissociating before
PPi and Pi, which subsequently dissociate
randomly. Apparently, Pi binding prevents access of both
ATP and methionine to their binding sites. This kinetic mechanism is
illustrated in Scheme 1. The finding that
none of the inhibition patterns are uncompetitive, and that at least
one product is a competitive inhibitor with each substrate, in
conjunction with the dead-end and alternative substrate inhibition
data, shows that the only compatible kinetic scheme for the forward
reaction has random addition of ATP and methionine and partially random
product release (22). The noncompetitive inhibition by AdoMet toward
both substrates reflects formation of dead-end enzyme-substrate-AdoMet
complexes with both ATP and methionine, whereas the noncompetitive
inhibition by PPi with respect to methionine reflects
formation of a dead-end enzyme-methionine-PPi complex.
Because the kinetics of the reverse reaction could not be studied,
preferential binding order in that direction could not be further
evaluated.
|
The nonhydrolyzable PPPi analog diimidotriphosphate
(O3P-NH-PO2-NH-PO3) is a potent
inhibitor of the
-type EcMAT with a Ki of 2 nM (17). Approximately 50% inhibition of MjMAT was
observed at 2 µM PNPNP when enzyme, ATP, and methionine
were present at 5 µM, 0.5 mM, and 2.4 mM, respectively (at 55 °C). The same result was
obtained when the reaction was initiated by addition of enzyme or by
addition of substrates to a mixture of enzyme and PNPNP. Clearly PNPNP
has high affinity with a Ki of less than 2 µM. Because of the complexities of quantitative analysis
of tight binding inhibition (29), the details of the inhibition have
not yet been pursued.
The AdoMet metabolites S-adenosylhomocysteine (20 mM) and 5'-methylthioadenosine (5 mM) produced less than 10% inhibition when ATP and methionine were present at 0.2 and 0.5 mM, respectively, suggesting that these compounds are unlikely to be significant physiological regulators of enzyme activity. The AdoMet analog sinefungin was also a poor inhibitor, with 12 mM sinefungin giving less than 25% inhibition under these conditions.
Substrate Specificity-- Because AdoMet is the substrate of a large number of enzymes, the ability to prepare a variety of AdoMet analogs would be a valuable tool. EcMAT has been extensively used to prepare isotopically labeled AdoMet and some analogs despite limitations from severe product inhibition and significant substrate selectivity (14, 30, 31). The potential of MjMAT as a tool for synthesis of AdoMet analogs was assessed. Tables II and III compare the results for the use of ATP and methionine analogs by MjMAT and the E. coli enzyme. The tolerance of the ATP site of MjMAT is substantially greater than the bacterial enzyme, and MjMAT readily accepts modifications in both in the adenine and ribose moieties. For example, GTP, UTP, and CTP are substrates for MjMAT but not for EcMAT. Both 2'-deoxy- and 3'-deoxy-ATP are substrates for MjMAT, whereas only the latter is accepted by EcMAT.
|
|
Neither MjMAT nor EcMAT catalyzes AdoMet formation from analogs in which the scissile C-O bond is replaced by a C-S or C-N bond. The C5'-S and C5'-N containing compounds are good competitive inhibitors with respect to ATP, with Ki values near the Km for ATP for both enzymes.
The methionine site is rather restrictive in both MjMAT and EcMAT, but it is quantitatively different for the two enzymes (Table III). For both enzymes, the ethyl analog of L-methionine (i.e. L-ethionine) is a substrate, as is L-methionine methyl ester, but which is the better substrate differs for MjMAT and EcMAT. D-Methionine is also a substrate for both MjMAT and EcMAT. No activity was seen with either enzyme with the aldehyde methional, the alcohol methioninol, or 3-methylthio-propylamine, all of which lack one of the polar attachments present in methionine.
Temperature Dependence of Kinetic Parameters--
Fig.
4 illustrates an Arrhenius plot of the
temperature dependence of kcat for MjMAT and
EcMAT. The temperature dependence of kcat for
MjMAT is nonlinear. Because the enzyme was stable at elevated
temperatures and care was taken to measure initial reaction rates and
verify substrate saturation, the change in slope of the Arrhenius plot
apparently reflects a negative heat capacity
(
Cp) of activation (24). Analysis of the
temperature dependence of kcat using
H
S
Cp
0.3
kcal/mol-K, respectively, and the fit shown in Fig. 4. The negative
heat capacity change is consistent with a protein conformational
alteration during catalysis that results in a net decrease in exposure
of nonpolar surface area (32). Interestingly, the MjMAT and EcMAT have
comparable kcat values at approximately 37 and
70 °C, consistent with the optimal growth temperature for M. jannaschii of 87 °C. The
H
S
7 entropy units.
The Km values vary less than 3-fold over the ranges
studied for both enzymes, increasing with temperature in both
cases.
|
| |
DISCUSSION |
|---|
|
|
|---|
Despite the widely different sequences of the
- and
-types
of MAT, substantial similarities are present. Both classes of MAT
require Mg2+ for activity and are activated by
K+, although the monovalent cation is not essential. The
enzymes hydrolyze the PPPi, initially formed from ATP, to
yield PPi and Pi; the Pi largely
originates as the
-phosphoryl group of the nucleotide, indicating
that motion of PPPi is restricted within the active site.
Consistent with the tightly bound nature of the PPPi
intermediate, the nonhydrolyzable analog diimidotriphosphate is a
potent inhibitor of both MAT classes.
The steady state kinetic mechanism of MjMAT shows random substrate
binding and ordered product release, AdoMet dissociating before
PPi or Pi. Random substrate binding was
previously found for MAT from E. coli, whereas some eucaryal
MAT have ordered binding wherein ATP associates before methionine (8).
The order of product release in the MjMAT reaction is AdoMet before
PPi and Pi; with other MATs, both the same and
different orders of product release have been observed. A remarkable
property of MjMAT is the low affinity for AdoMet, with millimolar
Ki values, which contrasts with the
-type MATs
for which AdoMet typically inhibits with a Ki in the
physiologically significant 10
5 M range.
The substantial substrate activity of common naturally occurring nucleotides other than ATP, such as 2'-deoxy-ATP, GTP, CTP, and UTP, is surprising. Although the higher Km values compared with ATP and the probable lower intracellular concentrations of the other triphosphates may render the in vivo synthesis of large amounts of the corresponding sulfonium ions unlikely, whether physiologically significant quantities are made in vivo is as yet unclear. Thus, it is possible that there is an additional in vivo role of this enzyme in producing hitherto unknown sulfonium metabolite. Such an as yet unidentified enzymatic role might rationalize why the primitive bacterium Aquifex aeolicus, which has one of the smallest genomes known for a free living organism, harbors genes for both classes of MAT (11).
The comparable activity of the M. jannaschii and E. coli enzymes near their physiological temperatures reflects the "principle of corresponding temperature" (33) and suggests a similar extent of utilization of AdoMet in these organisms. The thermal lability of AdoMet, both in chirality at the sulfonium center and in covalent bonding (34), requires a substantial metabolic flux through the synthetic reaction to maintain a pool of substrate for further metabolic requirements. The larger apparent activation energy for the MjMAT in the 0-37 °C range reflects an increase in the apparent enthalpy of activation, whereas there is a more favorable entropy of activation. These observations are consistent with the notion that enzymes from organisms that inhabit warmer environments are "stiffer" than those from cooler habitats (23).
The tolerance of MjMAT for chemical alterations of both the methionine
and ATP moieties, the low affinity for the product AdoMet, in
conjunction with the stability of the protein, suggests that this
enzyme may be a useful synthetic tool for preparation of AdoMet
analogs. In view of the myriad of roles of AdoMet in metabolism, and
the paucity of available analogs, the feasibility of these syntheses
are being explored.
| |
ACKNOWLEDGEMENTS |
|---|
We thank John C. Taylor for aid throughout this project and the Fox Chase Organic Synthesis Facility for preparation of the diimidotriphosphate.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grants GM31186 and CA06927 and by an appropriation from the Commonwealth of Pennsylvania.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Fox Chase Cancer
Center, Inst. for Cancer Research, 7701 Burholme Ave., Philadelphia, PA
19111. Tel.: 215-728-2439; Fax: 215-728-3574; E-mail: gd_markham@fccc.edu.
Published, JBC Papers in Press, February 28, 2002, DOI 10.1074/jbc.M110456200
2 Z. J. Lu and G. D. Markham, unpublished results.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: AdoMet, S-adenosyl-L-methionine; A(NH)TP, 5'-amino-5'-deoxy-ATP; A(S)TP, 5'-mercapto-5'-deoxy-ATP; PNPNP, diimidotriphosphate (O3P-NH-PO2-NH-PO3); PPPi, tripolyphosphate; MAT, S-adenosylmethionine synthetase; EcMAT, S-adenosylmethionine synthetase from E. coli; MjMAT, S-adenosylmethionine synthetase from M. jannaschii; DTT, dithiothreitol; MES, 4-morpholineethanesulfonic acid.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Tabor, C. W.,
and Tabor, H.
(1984)
Annu. Rev. Biochem.
53,
749-790[CrossRef][Medline]
[Order article via Infotrieve] |
| 2. |
Cantoni, G. L.
(1975)
Annu. Rev. Biochem.
44,
435-451[CrossRef][Medline]
[Order article via Infotrieve] |
| 3. |
Chiang, P. K.,
Gordon, R. K.,
Tal, J.,
Zeng, G. C.,
Doctor, B. P.,
Pardhasaradhi, K.,
and McCann, P. P.
(1996)
FASEB J.
10,
471-480[Abstract] |
| 4. |
Frey, P. A.
(2001)
Annu. Rev. Biochem.
70,
121-148[CrossRef][Medline]
[Order article via Infotrieve] |
| 5. |
Sofia, H. J.,
Chen, G.,
Hetzler, B. G.,
Reyes-Spindola, J. F.,
and Miller, N. E.
(2001)
Nucleic Acids Res.
29,
1097-1106 |
| 6. | Mudd, S. H. (1973) in The Enzymes (Boyer, P. D., ed), 3rd Ed., Vol. 8 , pp. 21-154, Academic Press, New York |
| 7. |
Mato, J. M.,
Alvarez, L.,
Ortiz, P.,
and Pajares, M. A.
(1997)
Pharmacol. Ther.
73,
265-280[CrossRef][Medline]
[Order article via Infotrieve] |
| 8. |
Kotb, M.,
and Geller, A. M.
(1993)
Pharmacol. Ther.
59,
125-143[CrossRef][Medline]
[Order article via Infotrieve] |
| 9. |
Tabor, C. W.,
and Tabor, H.
(1984)
Adv. Enzymol.
56,
251-282[Medline]
[Order article via Infotrieve] |
| 10. |
Kotb, M.,
Mudd, S. H.,
Mato, J. M.,
Geller, A. M.,
Kredich, N. M.,
Chou, J. Y.,
and Cantoni, G. L.
(1997)
Trends Genet.
13,
51-52[CrossRef][Medline]
[Order article via Infotrieve] |
| 11. |
Graham, D. E.,
Bock, C. L.,
Schalk-Hihi, C., Lu, Z. J.,
and Markham, G. D.
(2000)
J. Biol. Chem.
275,
4055-4059 |
| 12. |
McQueney, M. S.,
Anderson, K. S.,
and Markham, G. D.
(2000)
Biochemistry
39,
4443-4454[CrossRef][Medline]
[Order article via Infotrieve] |
| 13. |
Trowbridge, D. B.,
Yamamoto, D. M.,
and Kenyon, G. L.
(1972)
J. Am. Chem. Soc.
94,
3816-3824[CrossRef][Medline]
[Order article via Infotrieve] |
| 14. |
Markham, G. D.,
Hafner, E. W.,
Tabor, C. W.,
and Tabor, H.
(1980)
J. Biol. Chem.
255,
9082-9092 |
| 15. |
Ma, Q. F.,
Kenyon, G. L.,
and Markham, G. D.
(1990)
Biochemistry
29,
1412-1416[CrossRef][Medline]
[Order article via Infotrieve] |
| 16. |
Taylor, J. C.,
and Markham, G. D.
(2000)
J. Biol. Chem.
275,
4060-4065 |
| 17. |
Reczkowski, R. S.,
and Markham, G. D.
(1999)
Biochemistry
38,
9063-9068[CrossRef][Medline]
[Order article via Infotrieve] |
| 18. |
Sufrin, J. R.,
Lombardini, J. B.,
and Keith, D. D.
(1982)
Biochem. Biophys. Res. Commun.
106,
251-255[CrossRef][Medline]
[Order article via Infotrieve] |
| 19. | Genetics Computer Group. (1999) Peptidesort, Version 10 , Genetics Computer Group, Madison, WI |
| 20. |
Reczkowski, R. S.,
Taylor, J. C.,
and Markham, G. D.
(1998)
Biochemistry
37,
13499-13506[CrossRef][Medline]
[Order article via Infotrieve] |
| 21. |
Cleland, W. W.
(1979)
Methods Enzymol.
63,
103-138[Medline]
[Order article via Infotrieve] |
| 22. | Segel, I. H. (1975) Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady State Enzyme Systems , Wiley-Interscience, New York |
| 23. |
Lonhienne, T.,
Gerday, C.,
and Feller, G.
(2000)
Biochim. Biophys. Acta
1543,
1-10[CrossRef][Medline]
[Order article via Infotrieve] |
| 24. |
Cooper, A.,
Johnson, C. M.,
Lakey, J. H.,
and Nollmann, M.
(2001)
Biophys. Chem.
93,
215-230[CrossRef][Medline]
[Order article via Infotrieve] |
| 25. |
Dunaway-Mariano, D.,
and Cleland, W. W.
(1980)
Biochemistry
19,
1496-1505[CrossRef][Medline]
[Order article via Infotrieve] |
| 26. |
Takusagawa, F.,
Kamitori, S.,
Misaki, S.,
and Markham, G. D.
(1996)
J. Biol. Chem.
271,
136-147 |
| 27. |
Gonzalez, B.,
Pajares, M. A.,
Hermoso, J. A.,
Alvarez, L.,
Garrido, F.,
Sufrin, J. R.,
and Sanz-Aparicio, J.
(2000)
J. Mol. Biol.
300,
363-375[CrossRef][Medline]
[Order article via Infotrieve] |
| 28. |
Coulter, A. W.,
Lombardini, J. B.,
Sufrin, J. R.,
and Talalay, P.
(1974)
Mol. Pharmacol.
10,
319-334 |
| 29. |
Szedlacsek, S. E.,
and Duggleby, R. G.
(1995)
Methods Enzymol.
249,
144-180[Medline]
[Order article via Infotrieve] |
| 30. |
Park, J.,
Tai, J.,
Roessner, C. A.,
and Scott, A. I.
(1996)
Bioorg. Med. Chem.
4,
2179-2185[CrossRef][Medline]
[Order article via Infotrieve] |
| 31. |
Kaiser, I. I.,
Kladianos, D. M.,
Van Kirk, E. A.,
and Haley, B. E.
(1983)
J. Biol. Chem.
258,
1747-1751 |
| 32. |
Murphy, K. P.,
and Freire, E.
(1992)
Adv. Protein Chem.
43,
313-361[Medline]
[Order article via Infotrieve] |
| 33. |
Somero, G. N.
(1995)
Annu. Rev. Physiol.
57,
43-68[CrossRef][Medline]
[Order article via Infotrieve] |
| 34. |
Hoffman, J. L.
(1986)
Biochemistry
25,
4444-4449[CrossRef][Medline]
[Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
N. Sun, F. Beck, R. W. Knispel, F. Siedler, B. Scheffer, S. Nickell, W. Baumeister, and I. Nagy Proteomics Analysis of Thermoplasma acidophilum with a Focus on Protein Complexes Mol. Cell. Proteomics, March 1, 2007; 6(3): 492 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Graham, H. Xu, and R. H. White Methanococcus jannaschii Uses a Pyruvoyl-dependent Arginine Decarboxylase in Polyamine Biosynthesis J. Biol. Chem., June 21, 2002; 277(26): 23500 - 23507. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||